MS patients treated with FTY showed the highest percentage of CD4+ T cells producing GRZB and the lowest percentage of CD4+ T cells producing IL-2, displaying a more cytotoxic profile, that is typically found in autoimmune diseases and, in particular, during MS (Fig. 3A). Here, CD4 is linked to myeloid sarcoma.